Investing in our most vulnerable: The COVID-19 Immunity Task Force funds comprehensive new SARS-CoV-2 seroprevalence study focused on aging Canadians

Press/Media: Research

PeriodOct 1 2020

Media coverage

10

Media coverage

  • TitleInvesting in our most vulnerable: The COVID-19 Immunity Task Force funds comprehensive new SARS-CoV-2 seroprevalence study focused on aging Canadians
    Media name/outletMarkets Business Insider
    Country/TerritoryUnited States
    Date10/1/20
    PersonsSusan Kirkland
  • TitleInvesting in our most vulnerable: The COVID-19 Immunity Task Force funds comprehensive new SARS-CoV-2 seroprevalence study focused on aging Canadians
    Media name/outletJotup
    Country/TerritoryUnited States
    Date10/1/20
    PersonsSusan Kirkland
  • TitleInvesting in our most vulnerable: The COVID-19 Immunity Task Force funds comprehensive new SARS-CoV-2 seroprevalence study focused on aging Canadians
    Media name/outletMed e-News - McGill Publications
    Country/TerritoryCanada
    Date10/1/20
    PersonsSusan Kirkland
  • TitleInvesting in our most vulnerable: The COVID-19 Immunity Task Force funds comprehensive new SARS-CoV-2 seroprevalence study focused on aging Canadians
    Media name/outletMcGill University
    Country/TerritoryCanada
    Date10/1/20
    PersonsSusan Kirkland
  • TitleInvesting in our most vulnerable: The COVID-19 Immunity Task Force funds comprehensive new SARS-CoV-2 seroprevalence study focused on aging Canadians
    Media name/outletGlobeNewswire
    Country/TerritoryUnited States
    Date10/1/20
    PersonsSusan Kirkland
  • TitleInvesting in our most vulnerable: The COVID-19 Immunity Task Force funds comprehensive new SARS-CoV-2 seroprevalence study focused ...
    Media name/outletEIN Presswire
    Country/TerritoryUnited States
    Date10/1/20
    PersonsSusan Kirkland
  • TitleInvesting in our most vulnerable: The COVID-19 Immunity Task Force funds comprehensive new SARS-CoV-2 seroprevalence study focused on aging Canadians
    Media name/outletNewbridge Securities Corporation
    Country/TerritoryUnited States
    Date10/1/20
    PersonsSusan Kirkland
  • TitleInvesting in our most vulnerable: The COVID-19 Immunity Task Force funds comprehensive new SARS-CoV-2 seroprevalence study focused on aging Canadians
    Media name/outletPrimeNewswire (Top News)
    Country/TerritoryUnited States
    Date10/1/20
    PersonsSusan Kirkland
  • TitleInvesting in our most vulnerable: The COVID-19 Immunity Task Force funds comprehensive new SARS-CoV-2 seroprevalence study focused on aging Canadians
    Media name/outletBizWire Express
    Country/TerritoryIndia
    Date10/1/20
    PersonsSusan Kirkland
  • TitleCOVID-19 Immunity Task Force funds comprehensive new SARS-CoV-2 seroprevalence study focused on aging Canadians
    Media name/outletMirage News
    Country/TerritoryAustralia
    Date10/1/20
    PersonsSusan Kirkland